Search

everythinglearnresearchcommunity

for

Search:↓

The zinc finger protein 3 in Arabidopsis thaliana reduces plant growth and root hair development.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Giving a special protein to dogs with a certain genetic disease improved their symptoms but didn't help with hair growth.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Age, gender, and hair loss affect scalp characteristics differently in young Caucasian adults.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Alopecia patients have less GPER-1, which might affect hair loss.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Taking calcium may help elderly with osteoporosis, birth control with levonorgestrel doesn't increase heart attack risk, Salmonella can cause arthritis, a national ethics committee is recommended, and sulfasalazine might help with a hair loss condition.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

PRP is more effective than minoxidil and placebo for treating hair loss.

The Hair Check tool can measure hair loss, but patients' own reports are more reliable for assessing hair loss during chemotherapy.

The document likely discusses how to tell the difference between excessive hair growth and the development of male characteristics in women.

Post-COVID-19 hair loss is likely due to stress and inflammation.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Micropigmentation effectively hides scalp scars with few complications.

The article suggests that the view of male baldness as a medical issue is influenced by commercial bias and calls for more unbiased research.

Bioaesthetic therapies could improve healthcare if they safely regenerate cells, tissues, or organs to restore normal function.

Both low-level light therapy and 5% minoxidil are effective and safe for treating male hair loss, with no significant difference in results.

Both Betasalic ointment and 5% minoxidil are effective and safe for treating Alopecia Areata.

Dr. Shiell concludes that good communication, proper training, and thorough documentation can help avoid legal issues in cosmetic surgery.

The document concludes that H2-antagonists and proton pump inhibitors are highly effective for ulcers, eradicating Helicobacter pylori is important to prevent recurrence, and misoprostol helps with NSAID-related ulcers.

Thorough patient interviews are crucial to identify self-inflicted hair loss.